pbsv_8k.htm
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM
8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 or
15(d) OF THE
SECURITIES EXCHANGE
ACT OF 1934
Date of report
(Date of earliest event reported): September 28,
2017
Pharma-Bio
Serv, Inc.
(Exact Name of
Registrant as Specified in Its Charter)
Delaware
(State or Other
Jurisdiction of Incorporation)
|
0-50956
|
20-0653570
|
|
(Commission File
Number)
|
(I.R.S. Employer
Identification No.)
|
|
6 Road 696, Dorado,
Puerto Rico
|
00646
|
|
(Address of
Principal Executive Offices)
|
(Zip
Code)
|
|
(787)
278-2709
|
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
|
|
(Former Name or
Former Address, if Changed Since Last Report)
|
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02.
Results of Operations and Financial Condition.
On September 28,
2017, Pharma-Bio Serv, Inc. (the “Company”) issued a
press release providing an update of its operations following
Hurricane Maria. A copy of the press release is furnished as
Exhibit 99.1 to this report.
Item
9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
|
|
Press Release,
dated September 28, 2017
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
PHARMA-BIO SERV,
INC.
|
|
|
|
|
|
|
|
Date:
September 28, 2017
|
By:
|
/s/ Pedro J.
Lasanta
|
|
|
|
|
Pedro J.
Lasanta
|
|
|
|
|
Chief Financial
Officer, Vice President Finance and Administration and
Secretary
|
|
|
|
|
|
|
EXHIBIT
INDEX
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
|
|
Press Release,
dated September 28, 2017
|